| Abbreviation | Full Text |
| 2-AG | 2-arachidonoyl glycerol |
| ABHD4 | Abhydrolase Domain Containing 4, N-Acyl Phospholipase B |
| AD | Alzheimer’s Disease |
| AEA | Arachidonyol ethanolammide or anandamide |
| ALS | Amyotrophic Lateral Sclerosis |
| ASCL1 | Achaete-scute homolog 1 |
| Aβ | Beta-amyloid |
| BCL11B | B-cell lymphoma/leukemia 11B |
| BDNF | Brain-derived neurotrophic factor |
| BdrU | Bromodeoxyuridine |
| CAM | Cell adhesion molecules |
| cAMP | Cyclic adenosine monophosphate |
| CB1 | Cannabinoid receptor 1 |
| CB2 | Cannabinoid Receptor 2 |
| CBD | Cannabidiol |
| CBDA | Cannabidiolic acid |
| CBG | Cannabigerol |
| CBGA | Cannabigerolic acid |
| CBN | Cannabinol |
| CDC42 | Cell Division Cycle 42 |
| CDKN1C | Cyclin-dependent kinase inhibitor 1C |
| CR | Calretinin |
| CREB | cAMP response element-binding protein |
| DAGL | Ciacylglycerol lipase |
| Dcc | Transmembrane protein deleted in colorectal cancer |
| DCX | Doublecortin |
| DG | Dentate gyrus |
| EMCDDA | European Monitoring Center for Drugs and Drugs Addiction |
| ERK | Extracellular signal-regulated kinases |
| FAAH | Fatty acid amide hydrolase |
| FDA | Food and Drug Administration |
| FGFR | Fibroblast growth factor receptors |
| FST | Force swimming test |
| GABA | Gamma-aminobutyric acid |
| GDE1 | Glycerophosphodiesterase 1 |
| GFAP | Glial fibrillary acidic protein |
| GPP | Geranylpyrophosphate |
| GPR55 | G protein-coupled receptor 55 |
| GSK3β | glycogen synthase kinase 3 beta |
| hiPS | Human induced pluripotent stem |
| IL | Interleukin |
| IL1-RA | Interleukin-1 receptor antagonist |
| JNK | c-Jun N-terminal kinase |
| Ki-67 | Antigen Ki-67 |
| KROX-24 | Early growth response protein 1 |
| LTP | Long term potentiation |
| MAP-2 | Microtubule-associated protein 2 |
| MAPKs | Mitogen-activated protein kinases |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| mTORC | Mechanistic target of rapamycin complex |
| NAE | N-acyl-ethanolamine |
| NAPE | N-acylphosphatidylethanolamine |
| NAPE-PDL | N-acylphosphatidylethanolamine phospholipase D |
| NAT | N-acyltransferase |
| NeuN | Hexaribonucleotide Binding Protein-3 |
| NeuroD1 | Neurogenic differentiation 1 |
| NF-kB | Transcription factors like nuclear factor kappa-light-chain-enhancer of activated B cells |
| NPCs | Neuronal progenitor cells |
| NSCs | Neural stem cells |
| p27Kip1 | Cyclin-dependent kinase inhibitor 1B protein |
| Pals1 | Protein associated with Lin-7 |
| PD | Parkinson’s Disease |
| PI3K/AKT | Phosphoinositide 3-kinases/protein kinase B |
| PINK1 | PTEN-induced kinase 1 |
| PIP2 | Phosphatidylinositol 4,5-bisphosphate |
| PLC | NAPE-phospholipase C |
| PLCβ | Phospholipase C-β |
| PPARγ | Peroxisome proliferator- activated receptor gamma |
| Prox1 | Prospero related homeobox gene |
| PSA-NCAM | Polysialylated-neural cell adhesion molecule |
| Rhoa | Ras homolog gene family members A |
| ROCK | Rho-associated protein kinase |
| SGK1 | Serum and glucocorticoid-regulated kinase 1 |
| SGZ | Subgranular zone |
| SOX2 | Sex determining region Y-box 2 |
| STAT3 | Signal transducer and activator of transcription 3 |
| SVZ | Subventricular zone of the lateral ventricle |
| THC | Δ9-tetrahydrocannabinol |
| TLX | Nuclear receptor subfamily 2 group E member 1 |
| TNFα | Tumor necrosis factor alpha |
| TrkA | Tropomyosin receptor kinase A |
| TRPV1 | Transient receptor potential cation channel subfamily V member 1 |
| Tuj1 | β-tubulin isoform III |
| UNC5C | UNC-5 netrin receptor C |
| Δ1-THCA | Δ1-tetrahydrocannabinolic acid |